NYSE:NVO
Novo Nordisk A/S Stock News
$132.80
+0.120 (+0.0904%)
At Close: May 30, 2024
Novo Nordisk (NVO) Q2 2022 Earnings Call Transcript
02:00pm, Thursday, 04'th Aug 2022 The Motley Fool
NVO earnings call for the period ending June 30, 2022.
Alibaba, MercadoLibre And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
11:59am, Thursday, 04'th Aug 2022 Benzinga
Global Blood Therapeutics, Inc. (NASDAQ: GBT) rose 19.3% to $40.47 in pre-market trading following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, cit
Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket
10:51am, Thursday, 04'th Aug 2022 Benzinga
Gainers
Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on Wednesday.
GreenLight Biosciences Holdings (NASDAQ: GRNA) shares rose 100.6% to $6.54 i
Novo Nordisk CEO on treating diabetes and obesity, and challenges facing the industry
09:09am, Thursday, 04'th Aug 2022
Novo Nordisk CEO Lars Jorgensen discusses the company's latest results, developing and supplying the world with medication and devices to treat diabetes, and logistical challenges facing the company a
Obesity drug supply delay not unusual says Novo Nordisk CEO
05:40am, Thursday, 04'th Aug 2022
Novo Nordisk sought to soothe concerns about supplies of its new obesity drug Wegovy on Thursday, saying there was nothing unusual about a slight delay in its availability.
Novo Nordisk A/S (NVO) CEO Lars Fruergaard Joergensen on Q2 2022 Results - Earnings Call Transcript
08:50pm, Wednesday, 03'rd Aug 2022
Novo Nordisk A/S (NVO) Q2 2022 Earnings Conference Call August 3, 2022 1:30 PM ET Company Participants Lars Fruergaard Joergensen - Chief Executive Officer Camilla Sylvest - Executive Vice President &
AMD, SolarEdge Technologies And Some Other Big Stocks Moving Lower On Wednesday
03:33pm, Wednesday, 03'rd Aug 2022 Benzinga
Rocky Brands, Inc. (NASDAQ: RCKY) dipped 21.6% to $26.62 after the company reported worse-than-expected Q2 EPS results.
Horizon Therapeutics Public Limited Company (NASDAQ: HZNP) dropped 21.3% to $64
Drug, Biotech Stocks' Q2 Earnings on Aug 4: LLY, AMGN & More
01:48pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Let us look at four large drug and biotech companies, AMGN, VRTX, LLY, NVO, which are gearing up for their earnings release.
Novo Nordisk's Obesity Sales Nearly Doubled, But That Wasn't Enough For NVO Stock
12:23pm, Wednesday, 03'rd Aug 2022
Danish drugmaker Novo Nordisk missed quarterly views Wednesday, but raised its full-year outlook. Still, NVO stock tumbled.
Novo Nordisk raises 2022 outlook after strong first half
10:39am, Wednesday, 03'rd Aug 2022
Danish drugmaker Novo Nordisk on Wednesday lifted its sales and operating profit outlook for the year on the back of strong first-half earnings.
Novo Nordisk (NVO) to Report Q2 Earnings: What's in the Cards?
04:07pm, Monday, 01'st Aug 2022 Zacks Investment Research
Novo Nordisk's (NVO) top line is likely to have been driven by sales of its Diabetes and Obesity Care products in the second quarter of 2022.
Alnylam's Strategy Is Getting Bigger. Time to Buy?
09:31am, Saturday, 30'th Jul 2022 The Motley Fool
After decades of developing rare-disease drugs, this RNA pioneer will aim for much larger audiences.
2 High-Yield Dividend Aristocrats Potentially Set To Soar And 10 You Should Ignore
01:15pm, Saturday, 23'rd Jul 2022 Seeking Alpha
Dividends are an essential part of achieving life-changing wealth in the stock market. Click here for 2 high-yield dividend aristocrats potentially set to soar.
2 Pharma Giants With Momentum That Could Carry Through 2030
03:30pm, Friday, 22'nd Jul 2022 The Motley Fool
An obese population could drive competition toward a valuable market.
The Zacks Analyst Blog Highlights AMN Healthcare, Boeing, Clorox, Novo Nordisk and Costco Wholesale
10:40am, Tuesday, 19'th Jul 2022 Zacks Investment Research
AMN Healthcare, Boeing, Clorox, Novo Nordisk and Costco Wholesale have been included in this Analyst Blog.
